Full-Time

Sr. Director/Executive Director MD

Immunology Clinical Development

Confirmed live in the last 24 hours

Neurocrine Biosciences

Neurocrine Biosciences

1,001-5,000 employees

Biotechnology
Healthcare

Compensation Overview

$294.1k - $425.9kAnnually

+ Bonus + Equity Incentive Program

Senior

San Diego, CA, USA

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Requirements
  • MD or DO required
  • At least 6+ years of experience in clinical research and development (Phase I-IV) in immunological or autoimmune disorders in either a pharmaceutical/biotechnology company or a clinical research/academic environment or related experience required.
  • Extensive previous leadership experience also required
  • Acts as a subject matter expert or 'trusted advisor' across the company and may be recognized as an external expert.
  • Provides strategy, vision, leadership and direction on clinical development programs or other projects regarding clinical/medical issues
  • Requires in-depth knowledge of the functional area and business needs
  • Possesses industry-leading knowledge
  • Excellent organizational skills
  • Excellent presentation, written and verbal communication skills
  • Ability to synthesize data from multiple sources and modalities and apply advanced analytical thought and judgment
  • Strong leadership, collaboration, and employee development skills
  • Ability to influence others with or without authority at all levels of the organization
  • Proactive, innovative, with excellent problem-solving and decision making skills
  • Ability to work in a cross functional team and matrix environment
  • High degree of planning ability in coordinating the activities of clinical investigations within the limits of clinical research schedules
  • Extensive knowledge of federal regulations regarding clinical studies and the conduct of clinical studies
  • Effective interpersonal skills (ability to be personable and establish good rapport with investigators, study coordinators, and other study personnel)
Responsibilities
  • Drive strategic direction for organizational plans and policies for clinical trials/research and data collection activities.
  • Responsible for the implementation of clinical projects
  • Create and foster strong relationships with investigators
  • Collaborates with senior management in the development of strategies, research plans, budgets, and clinical summaries
  • Monitor adherence to protocols
  • Supervise the organization of monitoring procedures and collection of data
  • Synthesize study-related data from multiple sources to drive study/program strategy
  • Monitor clinical trials directly and indirectly through assigned CRAs and CROs
  • Provide necessary input for Investigator Brochures and FDA documents including IND and NDA documents
  • Collaborate on multidisciplinary project teams to deliver development goals
  • Participate in and speak at professional meetings
  • Provide clinical assessment or interpretation of data or literature in the preparation of final study reports, other regulatory documents or scientific publications
  • Anticipate factors that could impact Neurocrine’s strategies and its position in the field and recommend new or innovative solutions
  • Direct the development of protocols and study designs
  • Select, develop and evaluate clinical department personnel to ensure the efficient operation of the function
  • Other duties as assigned
Neurocrine Biosciences

Neurocrine Biosciences

View

Company Stage

IPO

Total Funding

N/A

Headquarters

San Diego, California

Founded

N/A

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • Positive Phase 2 data for NBI-1117568 in schizophrenia and the launch of INGREZZA SPRINKLE highlight Neurocrine's innovative pipeline and commitment to addressing unmet medical needs.
  • The FDA's acceptance of crinecerfont's New Drug Applications with Priority Review could lead to a significant market breakthrough if approved.
  • Recent investments and executive appointments suggest strong confidence in the company's future growth and strategic direction.

What critics are saying

  • The pharmaceutical industry is highly competitive, and Neurocrine must continuously innovate to maintain its market position.
  • Regulatory hurdles, such as FDA rejections, could delay product launches and impact financial performance.

What makes Neurocrine Biosciences unique

  • Neurocrine Biosciences is pioneering in the treatment of congenital adrenal hyperplasia (CAH) with crinecerfont, a first-in-class therapy that hasn't seen innovation in 70 years.
  • The company offers unique formulations like INGREZZA SPRINKLE, addressing specific patient needs such as dysphagia, which sets them apart in the pharmaceutical landscape.
  • Their focus on rare and serious endocrine disorders, combined with successful clinical trials, positions them as a leader in niche therapeutic areas.

Help us improve and share your feedback! Did you find this helpful?